Episurf Medical reaches milestone of 200 implants
Episurf Medical announces that the 200th implantation of the Episealer knee implant has been scheduled for the coming days. Episurf Medical’s unique, personalised technology continues to gain traction, enabling orthopaedic surgeons to successfully treat previously difficult to treat patients with cartilage and underlying bone lesions of the knee joint.“This is a significant milestone for Episurf Medical”, says Pål Ryfors, Acting CEO and CFO of Episurf Medical. “Our 200th Episealer implantation now clearly demonstrates that our technology is being accepted by more and more orthopaedic